Navigation Links
Genome scientists launch Microbiome journal
Date:1/9/2013

Two prominent microbiologists have launched a new peer-reviewed publication focusing on microbiome research in environmental, agricultural, and biomedical areas. Eric Wommack, from the University of Delaware's College of Earth, Ocean and Environment and Jacques Ravel, from the University of Maryland School of Medicine's Institute for Genome Sciences are the Editors-in-Chief of Microbiome, a BioMed Central (BMC) publication, which launched its first issue this week.

The new publication reflects the growing importance of the need for studying communities of microorganisms microbiomes and their functions in their natural environment whether that environment is the human body, the ocean, or any other habitat.

"Microbiology was once thought of as two exclusive subdisciplines clinical microbiology and environmental microbiology but the substantial technological advances, particularly over the past decade in DNA sequencing and analysis, have given scientists new common and interdisciplinary research interests," explains Ravel, who is studying the effect of the human microbiome on women's health, and is part of the NIH-funded Human Microbiome Project (HMP).

"Microbiome will facilitate the cross-fertilization of ideas, research methods and analyses, and theory between clinical and environmental microbiologists exploring the emergent impacts of microbial communities on the ecosystems they inhabit," says Wommack, a University of Delaware professor who researches the inner workings of microbial communities.

The central purpose of Microbiome is to unite investigators conducting research on microbial communities in environmental, agricultural, and biomedical arenas. Topics broadly addressing the study of microbial communities, such as, meta-genomics surveys, bioinformatics, other '-omics' approaches and surveys, and community/host interaction mathematical modeling will be covered.

The new issue of Microbiome features several innovative research papers from scientists at various institutions worldwide. For example, a team from the University of Guelph in Canada, summarized their novel stool substitute transplant therapy research. The team treated two patients with Clostridium difficile using a bacterial strain cocktail in an attempt to alleviate this difficult infection of the lower GI tract. Other innovative genomic research approaches are also featured in the first issue.

The journal includes a new section, "Microbiome Announcements," that will contain short reports describing microbiome datasets and their associated clinical or environmental data.

Jacques Ravel, is a professor of microbiology and immunology and associate director for genomics at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine. IGS scientists have pioneered studies in microbiome research and are continuing to be at the forefront of the human microbiome project. Eric Wommack, is a professor of environmental microbiology in the Departments of Plant and Soil Sciences, Biological Sciences, and the College of Earth, Ocean, and Environment at the University of Delaware.

A prestigious international editorial review board is working with Microbiome, including leading interdisciplinary scientists from the U.S., France, Australia, China and other countries, who represent academic centers, private and environmental research centers, as well as federal agencies. A number of present and former UD faculty are members of the editorial board, reflecting the leadership of the University of Delaware in community-scale microbiology research.


'/>"/>

Contact: Laura Crozier
crozier@dbi.udel.edu
302-831-3424
University of Delaware
Source:Eurekalert  

Related biology news :

1. Leading evolutionary scientist to discuss how genome of bacteria has evolved
2. Darwin in the genome
3. Analysis of stickleback genome sequence catches evolution in action
4. Athletic frogs have faster-changing genomes
5. PNAS: Precise molecular surgery in the plant genome
6. BGI and Aspera collaborate on high-speed data exchange to advance genome research
7. Researchers announce GenomeSpace environment to connect genomic tools
8. UC Santa Cruz builds national data center for cancer genome research
9. BGI reports the completed sequence of foxtail millet genome
10. Relative reference: Foxtail millet offers clues for assembling the switchgrass genome
11. Maps of Miscanthus genome offer insight into grass evolution
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genome scientists launch Microbiome journal
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: